Search result
Cell-specific targeting of therapeutic nucleic acids for tumor therapy
Institution: Abteilung für Klinische Pharmakologie, Klinikum der Universität München
Applicant : Dr. Lars König
Impact of HIF to the immunological tumor microenvironment and multi-drug testing in clear cell renal cell carcinoma
Institution: Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg
Applicant: Rouven Höfflin, Ian Frew
Single-cell characterization of synaptic transmission at the entorhino-hippocampal projection
Institution: Department of Neuroanatomy, Institute of Anatomy and Cell Biology. University of Freiburg
Applicant: Maximilian Lenz
Targeted Therapies
Institution: University Cancer Center (UCT) Frankfurt
Applicants: Prof. Simone Fulda, Prof. Christian Brandts
Investigation of Calca-encoded peptides to model divergent mechanisms governing bone regeneration
Institution: Department of Trauma, Hand, and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf
Applicant: Johannes Keller
In vivo investigations concerning the combinatorial treatment of medulloblastoma with 5-aza-2‘-deoxycytidine, abacavir, and irradiation
Institution: Department of Radiooncology, University of Leipzig
Applicant: Dr. Ina Patties
Tumor-specific protein signature of urinary bladder carcinoma
Institution: Institute of Pathology, University Medical Center Schleswig-Holstein, Luebeck Site
Applicant: Dr. med. Franz F. Dreßler
Erforschung der molekularen Grundlage des MIA-Proteins bei der Metastasierung im malignen Melanom
Institutions: Ruhr-Universität Bochum und Universitätsklinikum Essen
Applicants: Prof. Dr. Raphael Stoll und PD Dr. Iris Helfrich
Immune diagnostics of an hereditary cancer predisposition syndrome: A functional test for Lynch syndrome?
Institutions: Abteilung für Angewandte Tumor Biologie, Institut für Pathologie, Universitätsklinikum Heidelberg
Applicants: Matthias Kloor, Aysel Ahadova, Magnus von Knebel Doeberitz
Preclinical characterization of an innovative dual FXR/sEH modulator as experimental drug to treat non-alcoholic steatohepatitis
Institution: Institut für Pharmazeutische Chemie, Johann Wolfgang Goethe-Universität Frankfurt
Applicant: Dr. phil. nat. Daniel Merk, Johann Wolfgang Goethe-Universität Frankfurt